The GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTNEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →Same-day shipping now live from the US West Coast · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →
CBL-514 β€’ Research evidence

Comparing CBL-514 Trials Without Mixing the Evidence

Quick answerCBL-514 results from different trials should not be ranked by their largest headline percentage. Compare the question, design, measurement and analysis before deciding whether two results are commensurable.

Published November 14, 2026 Β· Disguised Alpha Β· Source-linked research guide

Research education only. These notes do not provide instructions for human use or establish that a supplier’s material is equivalent to a clinical study formulation.

Start with the study, not the headline

The early CBL-514 study used an open-label design, while later publications describe placebo-controlled studies.[1][2] A before-and-after comparison and a randomized between-group comparison are not equivalent evidence simply because they mention the same compound.

Make one row per study, not one row per press release. If a later publication reports a new analysis of the same trial, link it to that row so the participants are not counted twice.

An evidence table that preserves meaning

Our suggested columns are study identifier, population, comparator, endpoint, measurement method, endpoint visit, analysis population, estimate and uncertainty. Add a final limitations column for information that prevents direct comparison.

Illustrative mismatch: a 20% change in regional volume cannot be ranked against a 70% responder rate. The first describes a magnitude of change; the second describes how many participants crossed a defined threshold. They may both be positive findings while measuring fundamentally different things.

A similar mismatch occurs when one endpoint is measured from baseline and another is adjusted against placebo. Do not put both under a heading such as β€œfat loss” without preserving their definitions.

When pooling is premature

Combining results requires a defensible common question. Check for overlapping participants, different intervention formulations, incompatible measurements, different time windows and different definitions of response. An average across unlike quantities can be mathematically computable while scientifically uninterpretable.

FDA’s control-group guidance explains why the chosen comparison affects what a trial can demonstrate.[3] Our editorial approach is to describe the studies separately when there is no clear common basis, then identify where they agree and where they leave unresolved questions.

For a CBL-514 research review, a transparent table is often more useful than a single pooled percentage. It lets readers see whether additional evidence addresses the same question or expands into a different population, outcome or study design.

Frequently asked questions

Can the largest reported percentage identify the best study?

No. A percentage needs an endpoint, denominator, comparator and time point before it has an interpretable meaning.

Are several reports always independent confirmation?

No. Check trial identifiers and participant overlap before counting them as independent evidence.

Continue your CBL-514 research

Compare the original study evidence with the documentation for the specific material you are reviewing.

Sources and further reading

  1. Goodman et al., 2022 CBL-514 Phase IIa study
  2. Gold et al., 2025 CBL-514 trial
  3. FDA: E10 choice of control group

Publisher disclosure: Disguised Alpha is a research-material supplier. This guide is an educational interpretation of the linked sources, not an independent clinical review or a statement of regulatory approval.

References describe the studies or methods identified in the text. They do not independently certify the composition, clinical suitability or performance of Disguised Alpha products.

βœ“
Loading...
25% offGLPs15% off automaticallyUse code GLP or any code for 25% off0days00hrs00min00secShop the sale  →Shop